Dr. Reddy's Laboratories Ltd Common Stock vs UDR Inc. Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock and UDR Inc. Common Stock are close in size by market cap, and UDR Inc. Common Stock pays the higher dividend (5.12%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| RDY | UDR | |
|---|---|---|
Market Cap | $10.78B | $10.93B |
Volume | 2,724,343 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $15.38 | $41.24 |
52-Week Low | $11.38 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $16.96B |
Dividend Yield | 0.65% | 5.12% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →